Showing results (11-20 of 332) with videos related to
Sort By:
Pageof 34
The International Journal of Neuroscience|October 2, 2014
Experience with fingolimod in clinical practiceCarrie M Hersh, Claire Hara-Cleaver, Richard A Rudick, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2024
The onset presentation of multiple sclerosis differs in Hispanic/Latinx Americans compared with non-Hispanic White AmericansFarren Bs Briggs, Devon S Conway, Carrie M Hersh, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|October 1, 2022
Gadolinium-based contrast agent exposures and physical and cognitive disability in multiple sclerosisKunio Nakamura, Marisa P McGinley, Stephen E Jones, et al.Biomedicines|August 1, 2019
Diagnosis and Management of Progressive Multiple SclerosisGabrielle Macaron, Daniel OntanedaFrontiers in Neurology|February 22, 2021
Thalamic Injury and Cognition in Multiple SclerosisMoein Amin, Daniel OntanedaMultiple Sclerosis (Houndmills, Basingstoke, England)|April 2, 2019
MOG-related disorders: A new cause of imaging-negative myelitis?Gabrielle Macaron, Daniel OntanedaCurrent Opinion in Neurology|April 8, 2025
Re-defining progression in multiple sclerosisJeffrey Lambe, Daniel OntanedaBiomedicines|November 27, 2025
Evolving the Diagnosis of Multiple Sclerosis: A New Landscape in Light of the 2024 McDonald CriteriaAmjad Samara, Daniel OntanedaMultiple Sclerosis and Related Disorders|December 7, 2016
Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 12-month follow-upCarrie M Hersh, Thomas E Love, Samuel Cohn, et al.Pageof 34